Storia in 20 fonti

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly lucrative drug launch.

Raccontata da

cnbc.com+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo1 g fa

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

originale

Timeline cronologica

martedì 25 agosto 2026·letemps.ch
L’Agence américaine du médicament approuve le Rasonque, traitement très prometteur contre le cancer du pancréas - Le Temps
Le médicament utilisant le daraxonrasib vient d’être autorisé sur le sol américain, pour un coût de traitement d’environ de 40 000 dollars par mois. Des essais cliniques…
mercoledì 26 agosto 2026·biopharmadive.com
Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA
Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly…

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

Confronto fonti

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

Timeline cronologica

L’Agence américaine du médicament approuve le Rasonque, traitement très prometteur contre le cancer du pancréas - Le Temps

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves new drug Rasonque to treat advanced pancreatic cancer

FDA approves new pancreatic cancer drug expected to usher in new era of treatment

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

Rasonque nabs FDA approval for previously treated metastatic pancreatic adenocarcinoma

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA approves new pancreatic cancer drug expected to usher in new era of treatment

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA greenlights Revolution Medicines' pancreatic cancer gamechanger

FDA approves breakthrough drug to treat advanced pancreatic cancer

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | The Jerusalem Post

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

Tumore al pancreas, via in Usa alla nuova terapia: «Raddoppiata la sopravvivenza dei pazienti» - L'Unione Sarda.it

FDA approves new treatment for those with advanced pancreatic cancer - UPI.com